J&J's Alios BioPharma Reports Presented Positive Results of Anti-RSV Nucleoside Analog AL-8176
October 13, 2014 at 08:35 AM EDT
Alios BioPharma, Inc. presented results from a randomized, double-blind, placebo-controlled Phase 2 challenge study of its oral ...
